Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Spinal Trauma is Never without Sin: A Tetraplegia Patient Presented Without any Symptoms.

Efeoglu M, Akoglu H, Akoglu T, Eroglu SE, Onur OE, Denizbasi A.

Turk J Emerg Med. 2016 Mar 2;14(4):188-92. doi: 10.5505/1304.7361.2014.32848. eCollection 2014 Dec.

2.

Determination of the appropriate catheter length and place for needle thoracostomy by using computed tomography scans of pneumothorax patients.

Akoglu H, Akoglu EU, Evman S, Akoglu T, Altinok AD, Guneysel O, Onur OE, Eroglu SE.

Injury. 2013 Sep;44(9):1177-82. doi: 10.1016/j.injury.2012.10.005. Epub 2012 Oct 30.

PMID:
23116647
3.

Utility of cervical spinal and abdominal computed tomography in diagnosing occult pneumothorax in patients with blunt trauma: Computed tomographic imaging protocol matters.

Akoglu H, Akoglu EU, Evman S, Akoglu T, Denizbasi A, Guneysel O, Onur O, Onur E.

J Trauma Acute Care Surg. 2012 Oct;73(4):874-9. doi: 10.1097/TA.0b013e3182569ff2.

PMID:
22835995
4.

T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease.

Kibaroglu A, Eksioglu-Demiralp E, Akoglu T, Direskeneli H.

Clin Exp Rheumatol. 2004 Jul-Aug;22(4 Suppl 34):S59-63.

PMID:
15515788
5.

The effects of nitric oxide donors and inhibitors on neutrophil functions in Behçet's disease.

Atalay G, Eksioglu-Demiralp E, Akoglu T, Direskeneli H.

Clin Exp Rheumatol. 2002 Jul-Aug;20(4 Suppl 26):S17-20.

PMID:
12371629
6.

Effect of interferon-alpha(2a) on neutrophil adhesion and phagocytosis in chronic myeloid leukemia and Behçet's disease.

Kartí SS, Ovalí E, Ratip S, Cetiner M, Direskeneli H, Bayik M, Akoğlu T.

Clin Rheumatol. 2002 Jun;21(3):211-4.

PMID:
12111626
7.

Neutrophil activation in Behçet's disease.

Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T.

Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S19-24.

PMID:
11760393
8.

HSP 60 expression in mucocutaneous lesions of Behçet's disease.

Ergun T, Ince U, Ekşioğlu-Demiralp E, Direskeneli H, Gürbüz O, Gürses L, Aker F, Akoğlu T.

J Am Acad Dermatol. 2001 Dec;45(6):904-9.

PMID:
11712037
9.

Anticardiolipin antibodies in Behçet's disease: a reassessment.

Tokay S, Direskeneli H, Yurdakul S, Akoglu T.

Rheumatology (Oxford). 2001 Feb;40(2):192-5.

PMID:
11257156
10.

Remitting seronegative symmetrical synovitis with pitting oedema associated with chronic lymphocytic leukaemia.

Ekenel M, Yavuz S, Karti S, Direskeneli H, Akoğlu T.

Clin Rheumatol. 2000;19(3):247-8.

PMID:
10870667
11.

IL-8 producing cells in patients with Behçet's disease.

Mantas C, Direskeneli H, Oz D, Yavuz S, Akoglu T.

Clin Exp Rheumatol. 2000 Mar-Apr;18(2):249-51.

PMID:
10812500
12.

Role of hepatocyte growth factor in the development of dendritic cells from CD34+ bone marrow cells.

Ovali E, Ratip S, Kibaroglu A, Tekelioglu Y, Cetiner M, Karti S, Aydin F, Bayik M, Akoglu T.

Haematologica. 2000 May;85(5):464-9.

13.

Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.

Kurhan-Yavuz S, Direskeneli H, Bozkurt N, Ozyazgan Y, Bavbek T, Kazokoglu H, Eksioglu-Demiralp E, Wildner G, Diedrichs-Möhring M, Akoglu T.

Clin Exp Immunol. 2000 Apr;120(1):162-6.

14.

T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease.

Direskeneli H, Ekşioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T, Akoglu T.

J Rheumatol. 2000 Mar;27(3):708-13.

PMID:
10743813
15.

Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease.

Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T.

Rheumatol Int. 1999;19(1-2):23-6.

PMID:
10651077
16.
17.

Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome.

Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, Yazici H.

Rheumatology (Oxford). 1999 Aug;38(8):734-6.

PMID:
10501421
18.

Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever.

Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H.

J Rheumatol. 1999 Sep;26(9):1983-6.

PMID:
10493680
19.

Oligoclonal T cell expansions in patients with Behçet's disease.

Direskeneli H, Eksioglu-Demiralp E, Kibaroglu A, Yavuz S, Ergun T, Akoglu T.

Clin Exp Immunol. 1999 Jul;117(1):166-70.

20.

Double G0/G1 peak in the DNA histogram of aberrant marker positive acute leukemia patients is associated with a poor clinical outcome.

Ekşioğlu-Demiralp E, Budak-Alpdoğan T, Alpdoğan O, Atalay A, Ratip S, Oz D, Bayik M, Akoğlu T.

Leuk Lymphoma. 1999 May;33(5-6):567-72.

PMID:
10342584
21.

Levels of serum transforming growth factor-beta1 do not increase in Behçet's disease, in contrast to rheumatoid arthritis.

Eksioglu-Demiralp E, Direskeneli H, Akoglu T.

J Rheumatol. 1999 Apr;26(4):1010-1. No abstract available.

PMID:
10229441
22.

Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.

Ekşioglu-Demiralp E, Kibaroglu A, Direskeneli H, Yavuz S, Karsli F, Yurdakul S, Yazici H, Akoglu T.

J Rheumatol. 1999 Apr;26(4):826-32.

PMID:
10229403
23.

Serum levels of Th2 cytokines IL-4 and IL-10 in Behçet's disease.

Mantaş C, Direskeneli H, Ekşioglu-Demiralp E, Akoglu T.

J Rheumatol. 1999 Feb;26(2):510-2. No abstract available.

PMID:
9972999
24.

Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura.

Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T.

Br J Haematol. 1998 Dec;103(4):1061-3.

PMID:
9886319
25.

Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders.

Budak-Alpdogan T, Demirçay, Alpdogan O, Direskeneli H, Ergun T, Oztürk A, Günay A, Yavuz S, Uskent N, Akoğlu T.

Br J Rheumatol. 1998 Nov;37(11):1148-51.

PMID:
9851260
26.

Magnetic resonance imaging in myelofibrosis.

Alpdoğan O, Budak-Alpdoğan T, Bayik M, Akoğlu T, Kodalli N, Gürmen N.

Blood. 1998 Oct 15;92(8):2995-7. No abstract available.

27.

Phagocytosis and oxidative burst by neutrophils in patients with recurrent furunculosis.

Demirçay Z, Ekşioğlu-Demiralp E, Ergun T, Akoğlu T.

Br J Dermatol. 1998 Jun;138(6):1036-8.

PMID:
9747369
28.

Evaluation of chimerism with DNA polymorphisms in bone marrow transplantation.

Ozbek U, Vural B, Kalayoğlu S, Soysal T, Bilgen H, Yavuz S, Anak S, Sargin D, Gedikoğlu G, Ferhanoğlu B, Akoğlu T, Tangün Y, Ozçelik T.

Turk J Pediatr. 1997 Jul-Sep;39(3):303-11.

PMID:
9339108
29.

Behçet's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behçet's symptoms.

Budak-Alpdoğan T, Demirçay Z, Alpdoğan O, Direskeneli H, Ergun T, Bayik M, Akoğlu T.

Ann Hematol. 1997 Jan;74(1):45-8.

PMID:
9031616
30.

Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.

Eksioğlu-Demiralp E, Alpdoğan O, Aktan M, Firatli T, Oztürk A, Budak T, Bayik M, Akoğlu T.

Leukemia. 1996 Aug;10(8):1331-9.

PMID:
8709639
31.

Monocyte activity in Behçet's disease.

Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoğlu T.

Br J Rheumatol. 1996 May;35(5):424-9.

PMID:
8646431
32.

Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease.

Sahin S, Akoğlu T, Direskeneli H, Sen LS, Lawrence R.

Ann Rheum Dis. 1996 Feb;55(2):128-33.

33.

Re-evaluation of skin-explant model in graft-versus-host disease prediction.

Sahin S, Akoğlu TF, Gürbüz O, Ergun T, Küllü S, Sav A, Ahiskali R, Tüzüner N, Doğusoy G.

Clin Transplant. 1995 Oct;9(5):370-4.

PMID:
8541629
34.

A rapid and simple isolation of endothelial cell growth supplement from mouse brain.

Sahin S, Akoğlu T, Lawrence R, Sen LS.

Thromb Res. 1995 Jul 1;79(1):141-5. No abstract available.

PMID:
7495102
35.

The effect of 1,25 dihydroxyvitamin D3 on lymphocyte transformation in patients with chronic renal failure.

Alpdogan O, Ozgun S, Lawrence R, Ozener C, Akoglu E, Akoglu T.

Intern Med. 1995 Apr;34(4):240-2.

36.

Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease.

Direskeneli H, Keser G, D'Cruz D, Khamashta MA, Akoğlu T, Yazici H, Yurdakul S, Hamuryudan V, Ozgün S, Goral AJ, et al.

Clin Rheumatol. 1995 Jan;14(1):55-61.

PMID:
7743745
37.

Systemic interferon alpha 2b treatment in Behçet's syndrome.

Hamuryudan V, Moral F, Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Direskeneli H, Akoglu T, Yazici H.

J Rheumatol. 1994 Jun;21(6):1098-100.

PMID:
7932420
38.

Human leukocyte antigen subtype analysis in patients with advanced adenocarcinoma of the prostate.

Akdaş A, Türkeri L, Alican Y, Simşek F, Akoğlu T.

Prostate. 1994;24(3):111-3.

PMID:
7509482
39.

Treatment of thrombotic thrombocytopenic purpura with defibrotid.

Bayik MM, Akoglu T, Tuglular TF, Akoglu E, Tezal M, Ulutin O, Lawrence R.

Am J Hematol. 1993 May;43(1):74-5. No abstract available.

PMID:
8317470
40.

Subcutaneous nodules caused by Pseudomonas aeruginosa: healing without incision and drainage.

Korten V, Gürbüz O, Firatli T, Bayik M, Akoglu T.

J Chemother. 1992 Aug;4(4):225-7.

PMID:
1403078
41.

P-glycoprotein-mediated multidrug resistance and cytotoxic effector cells.

Savas B, Cole SP, Akoglu TF, Pross HF.

Nat Immun. 1992 Jul-Aug;11(4):177-92. Review.

PMID:
1358293
42.
43.

Megadose methylprednisolone pulse therapy in adult idiopathic thrombocytopenic purpura.

Akoğlu T, Paydaş S, Bayik M, Lawrence R, Firatli T.

Lancet. 1991 Jan 5;337(8732):56. No abstract available.

PMID:
1670680
44.

TNF, soluble IL-2R and soluble CD-8 in Behçet's disease.

Akoğlu TF, Direskeneli H, Yazici H, Lawrence R.

J Rheumatol. 1990 Aug;17(8):1107-8. No abstract available.

PMID:
2120438
45.
46.

Immunological studies in sickle cell disease: comparison of homozygote mild and severe variants.

Cetiner S, Akoğlu TF, Kilinç Y, Akoğlu E, Kümi M.

Clin Immunol Immunopathol. 1989 Oct;53(1):32-9. Erratum in: Clin Immunol Immunopathol 1990 Jun;55(3):492.

PMID:
2636864
47.

Non-Hodgkin's lymphomas in Turkey.

Sarpel SC, Paydas S, Tuncer I, Varinli S, Koksal M, Akoglu T.

Cancer. 1988 Oct 15;62(8):1653-7.

PMID:
3167781
49.

Mortality-lowering effect of systemic corticosteroid therapy in severe tetanus.

Paydaş S, Akoğlu TF, Akkiz H, Ozer FL, Burgut R.

Clin Ther. 1988;10(3):276-80.

PMID:
3078907
50.

Incomplete Behçet's syndrome with unusual manifestations.

Akoğlu T, Paydaş S, Sarpel S, Tunali N, Tuncer I.

Ann Rheum Dis. 1987 Aug;46(8):632-3.

Supplemental Content

Loading ...
Support Center